Search alternatives:
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
1361
Bivariate analysis of sociodemographic and other factors associated with the practice scores.
Published 2025Subjects: -
1362
-
1363
-
1364
-
1365
-
1366
-
1367
-
1368
-
1369
-
1370
-
1371
-
1372
Univariate and multivariate analysis of variables associated with good and poor responders to TFESI.
Published 2025Subjects: -
1373
-
1374
The serum concentrations of cytokines between good responders and poor responders to TFESI.
Published 2025Subjects: -
1375
Demographic data and baseline characteristics between good and poor responders to TFESI.
Published 2025Subjects: -
1376
-
1377
-
1378
Functional and strength parameters.
Published 2025“…An overall tendency to an increase in FF and a decrease in functional measures were observed over 2 years. …”
-
1379
<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate....
Published 2025“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
-
1380
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”